Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3679]

ASCO 2022: Autologous stem cell transplant showed improved progression-free survival in newly diagnosed multiple myeloma patients

ASCO 2022: Autologous stem cell transplant showed improved progression-free survival in newly diagnosed multiple...

ASCO 2022: Combination regimen improves overall survival in a type of newly diagnosed metastatic colorectal cancer

ASCO 2022: Combination regimen improves overall survival in a type of newly diagnosed metastatic colorectal cancer

ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein

ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein

ASCO 2022: Liquid biopsy can help identify the need for adjuvant therapy in stage II colon cancer

ASCO 2022: Liquid biopsy can help identify the need for adjuvant therapy in stage II colon cancer

ASCO 2022: Ibrutinib improves progression-free survival by 50% for older patients with newly diagnosed mantle cell lymphoma

ASCO 2022: Ibrutinib improves progression-free survival by 50% for older patients with newly diagnosed mantle cell...

'Masked' cancer drug sneaks through body to deliver anti-tumour treatment with fewer side effects

'Masked' cancer drug sneaks through body to deliver anti-tumour treatment with fewer side effects

The paired perils of breast cancer and diabetes

The paired perils of breast cancer and diabetes

Scientists identify new — and very common — subtype of prostate cancer

Scientists identify new — and very common — subtype of prostate cancer

Circular RNA circCCNB1 inhibits the migration and invasion of nasopharyngeal carcinoma through binding and stabilizing TJP1 mRNA

Circular RNA circCCNB1 inhibits the migration and invasion of nasopharyngeal carcinoma through binding and...

ECOG-ACRIN research highlights at ASCO 2022

ECOG-ACRIN research highlights at ASCO 2022

More from ecancer